Literature DB >> 7750631

Alternative mRNAs encode multiple isoforms of transcription factor AP-2 during murine embryogenesis.

P Meier1, M Koedood, J Philipp, A Fontana, P J Mitchell.   

Abstract

Transcription factor AP-2 has been implicated as an important regulator of gene expression during vertebrate embryogenesis. We report here the cDNA cloning and analysis of mouse embryonic mRNA splice variants encoding four AP-2 isoforms. Isoform 1 is the homolog of the previously known human (HeLa) AP-2. The three new AP-2 isoforms all share the same DNA binding/dimerization domain as isoform 1 but either lack the proline-rich transcriptional activation domain encoded by exon 2 (isoform 2) or have different amino-termini encoded by two previously unknown alternative first coding exons for AP-2 (isoforms 3 and 4). All four AP-2 mRNA variants are present at significant levels between Days 11.5 and 17.5 of mouse embryogenesis. Variants 1, 3, and 4 show qualitatively but not quantitatively similar restricted expression patterns in 8.5-12.5 dpc embryos examined by in situ hybridization. At mid-embryogenesis, variant 3 is the major AP-2 mRNA species in the nervous system and in total embryo RNA but is less prevalent than variants 1 and 4 in the epidermis. The four mRNAs are all induced, although unequally, during differentiation of P19 cells into neural cell types and by cAMP stimulation of primary astrocytes. Variants 1-3 are coexpressed in different ratios in HeLa cells and in three human glioblastoma cell lines. These findings reveal that transcriptional regulation by AP-2 is likely to be more complex than previously assumed given the potential for multiple AP-2 homo- and heterodimeric DNA binding forms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7750631     DOI: 10.1006/dbio.1995.1121

Source DB:  PubMed          Journal:  Dev Biol        ISSN: 0012-1606            Impact factor:   3.582


  12 in total

1.  Transcription factor AP-2alpha is preferentially cleaved by caspase 6 and degraded by proteasome during tumor necrosis factor alpha-induced apoptosis in breast cancer cells.

Authors:  O Nyormoi; Z Wang; D Doan; M Ruiz; D McConkey; M Bar-Eli
Journal:  Mol Cell Biol       Date:  2001-08       Impact factor: 4.272

2.  Comparative and functional analysis of the AP2 promoter indicates that conserved octamer and initiator elements are critical for activity.

Authors:  P C Creaser; D A D'Argenio; T Williams
Journal:  Nucleic Acids Res       Date:  1996-07-01       Impact factor: 16.971

3.  Overlapping Sp1 and AP2 binding sites in a promoter element of the lens-specific MIP gene.

Authors:  C Ohtaka-Maruyama; X Wang; H Ge; A B Chepelinsky
Journal:  Nucleic Acids Res       Date:  1998-01-15       Impact factor: 16.971

4.  Activation of an enhancer on the syndecan-1 gene is restricted to fibroblast growth factor family members in mesenchymal cells.

Authors:  P Jaakkola; T Vihinen; A Määttä; M Jalkanen
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

5.  AP-2 family members regulate basal and cAMP-induced expression of human chorionic gonadotropin.

Authors:  C LiCalsi; S Christophe; D J Steger; M Buescher; W Fischer; P L Mellon
Journal:  Nucleic Acids Res       Date:  2000-02-15       Impact factor: 16.971

6.  Aberrant expressions of AP-2α splice variants in pancreatic cancer.

Authors:  Catherine Carrière; Sarah Mirocha; Sophie Deharvengt; Jason R Gunn; Murray Korc
Journal:  Pancreas       Date:  2011-07       Impact factor: 3.327

7.  Derepression of the C/EBPalpha gene during adipogenesis: identification of AP-2alpha as a repressor.

Authors:  M S Jiang; Q Q Tang; J McLenithan; D Geiman; W Shillinglaw; W J Henzel; M D Lane
Journal:  Proc Natl Acad Sci U S A       Date:  1998-03-31       Impact factor: 11.205

8.  Sp1 and AP2 regulate but do not constitute TATA-less human TAF(II)55 core promoter activity.

Authors:  Tianyuan Zhou; Cheng-Ming Chiang
Journal:  Nucleic Acids Res       Date:  2002-10-01       Impact factor: 16.971

9.  Alternative TFAP2A isoforms have distinct activities in breast cancer.

Authors:  Chiara Berlato; KaYi V Chan; Anna M Price; Monica Canosa; Angelo G Scibetta; Helen C Hurst
Journal:  Breast Cancer Res       Date:  2011-03-04       Impact factor: 6.466

10.  Failure in post-transcriptional processing is a possible inactivation mechanism of AP-2alpha in cutaneous melanoma.

Authors:  J M Karjalainen; J K Kellokoski; A J Mannermaa; H E Kujala; K I Moisio; P J Mitchell; M J Eskelinen; E M Alhava; V M Kosma
Journal:  Br J Cancer       Date:  2000-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.